Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes

Cytomegalovirus (CMV) infection in kidney transplant recipients has been anecdotally observed with concomitant or subsequent opportunistic infections (OI), but this association has yet to be defined or quantified.

[1]  Deepali Kumar,et al.  Cytomegalovirus infection and graft rejection as risk factors for pneumocystis pneumonia in solid organ transplant recipients: A systematic review and meta‐analysis , 2018, Clinical transplantation.

[2]  G. Verleden,et al.  Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  C. Ensor,et al.  Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients , 2017, Antimicrobial Agents and Chemotherapy.

[4]  Su Hwan Lee,et al.  Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients , 2017, Scientific Reports.

[5]  F. Elzein,et al.  Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection , 2016, Case reports in transplantation.

[6]  N. Kamar,et al.  Pneumocystis Pneumonia in Solid-Organ Transplant Recipients , 2015, Journal of fungi.

[7]  J. Schold,et al.  CMV Viremia Is Associated With a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation , 2013, Transplantation.

[8]  Y. Solak,et al.  Cytomegalovirus and Aspergillus spp. coinfection in organ transplantation: a case report and review of the literature , 2012, CEN Case Reports.

[9]  A. Berger,et al.  A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  A. Åsberg,et al.  Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients , 2011, Transplantation.

[11]  S. Nasiri,et al.  Lack of cytomegalovirus and polyomavirus coexistence in Iranian kidney transplant recipients. , 2011, Transplantation proceedings.

[12]  E. Dodds-Ashley.  Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients , 2010, Pharmacotherapy.

[13]  A. Åsberg,et al.  Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  P. Carver,et al.  Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants , 2006, Pharmacotherapy.

[15]  D. Correa,et al.  Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant , 2006, Transplant infectious disease : an official journal of the Transplantation Society.

[16]  S. Jordan,et al.  Co-infection of Polyomavirus-BK and Cytomegalovirus in Renal Transplant Recipients , 2005, Transplantation.

[17]  M. Boeckh,et al.  High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. , 2002, The Journal of infectious diseases.

[18]  R. Rubin,et al.  Infection in organ-transplant recipients. , 1998, The New England journal of medicine.

[19]  D. Snydman,et al.  The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. , 1997, The American journal of medicine.

[20]  R. Rubin,et al.  Infection in the renal transplant recipient. , 1981, The American journal of medicine.

[21]  J. Moorhead,et al.  Infection in the Renal Transplant Patient , 1978, Journal of the Royal Society of Medicine.

[22]  이수환.  Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients , 2017 .

[23]  P. Meylan,et al.  Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[24]  R. Rubin,et al.  Clinical Approach to Infection in the Compromised Host , 2002, Springer US.

[25]  R. Rubin.  Infection in the Organ Transplant Recipient , 1994 .